참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|
| 반응물 | Pyridine | HCID 1049 | — |
| 반응물 | Dichloromethane | HCID 6344 | — |
| 반응물 | 2-Chloro-4H-1,3,2-benzodioxaphosphorin-4-one | HCID 237010 | — |
| 촉매 | Tetraethylammonium Bromide | HCID 6285 | — |
| 생성물 | Acridine | HCID 9215 | 65% |
반응 단계
To a cold, stirring methylene chloride solution (30 ml; 0° C.) of 2-chloro-4H-1,2,3-benzodioxaphosphorin-4-one (2.4 ml of 1M methylene chloride solution; 2.4 mmol) and pyridine (0.2 g; 2.4 mmol) was added the DMT-protected pseudonucleoside of Example 2, paragraph A (0.55 g; 0.8 mmol). After stirring at 0° C. for 1 hour, the reaction mixture was poured into 1M TEAB aqueous solution (60 ml). The organic solution was separated, dried, concentrated. The residue was purified by flash column chromatography, eluted with 1% Et3N/CH2Cl2, 1% Et3N/1%CH3OH/CH2Cl2. The combined fraction of the product was washed with 1M TEAB aqueous solution, dried over Na2SO4, and concentrated, affording 0.19 g, 65% of the phosphorylated DMT-protected acridine pseudonucleotide.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 특허 번호 | US05414077 |
|---|
| 출처 데이터셋 | uspto-grants-1995_05 |
|---|
| ORD ID | ord-13abdcc7b4664668a3fd37e4965d21df |
|---|
| 출처 메모 | uspto-grants-1995_05 |
|---|